Clinical Trials Directory

Trials / Sponsors / Akesobio Australia Pty Ltd

Akesobio Australia Pty Ltd

Industry · 9 registered clinical trials.

StatusTrialPhaseStarted
CompletedA Study to Evaluate the Safety, Pharmacokinetics, and Antitumor Activity of AK127 in Combination With AK104 in
Advanced or Metastatic Solid Tumours
EARLY_Phase 12021-10-12
TerminatedPhase 2 Study of Efficacy and Safety of AK120, in Subjects With Moderate-to-Severe Atopic Dermatitis
Atopic Dermatitis
Phase 22021-09-30
CompletedA Study of AK119 (Anti-CD73 Antibody), a Treatment for COVID-19, in Healthy Subjects
Coronavirus Disease 2019 (COVID-19)
Phase 12020-09-28
CompletedA Study of AK120 (IL-4Rα) in Healthy Subjects and Subjects With Moderate- to- Severe Atopic Dermatitis
Atopic Dermatitis
Phase 12020-06-15
CompletedA Study to Evaluate the Safety, Pharmacokinetics, and Antitumor Activity of AK117 as Monotherapy or in Combina
Neoplasms Malignant
Phase 12020-04-23
CompletedA Study of AK112, a PD-1/VEGF Bispecific Antibody, for Advanced Solid Tumors
Neoplasms Malignant
Phase 12019-09-20
CompletedA Study of AK111 in Healthy Subjects
Psoriasis
Phase 12018-08-14
CompletedStudy of the Safety, Pharmacokinetics, and Antitumor Activity of AK105 in Subjects With Advanced Solid Tumors
Advanced Cancer
Phase 12018-01-02
CompletedStudy of the Safety, Pharmacokinetics, and Antitumor Activity of AK104 in Subjects With Advanced Solid Tumors
Advanced Cancer
Phase 12017-10-03